RareNet 2026: Accelerating Discovery to Treatment in Rare Brain Disorders

RareNet 2026: Accelerating Discovery to Treatment in Rare Brain Disorders

Date: Tuesday, June 9, 2026
Location:
MIT Building 46, Singleton Auditorium (Room 46-3002), 524 Main Street, Cambridge, MA
Time: 8:45 a.m. – 4:30 PM with reception to follow
Registration is required

Symposium Overview

The pace of discovery in rare brain disorders has never been faster. Precision genetics, genome editing, RNA modulation, and targeted delivery platforms are redefining what is possible in the brain. Yet the path from discovery to effective treatment remains complex, capital-intensive, and often siloed across disorders and sectors.

RareNet 2026 brings together leaders from academia, biotechnology, and patient advocacy to build a more integrated translational model for rare brain disorders. By bridging discovery science with therapeutic engineering and real-world implementation, the symposium will explore practical strategies to overcome current bottlenecks in translation to clinical development.

Be sure to check this page for the most up-to-date event information.

Registration 

2026 RareNet Symposium Registration
First
Last
Please indicate if you would like to be considered for the poster session. Submission of a poster title does not guarantee selection

Symposium Schedule

8:45 – 9:00AMOPENING REMARKS
Guoping Feng, MIT McGovern Institute

9:00 – 9:35 AM – Feng Zhang, MIT McGovern Institute; Broad Institute

9:35 – 10:10 AM – Katherine High, Spark Therapeutics; Rockefeller University

10:10 – 10:45 AM – Kiran Musunuru, University of Pennsylvania

10:45 – 11:05 AM – COFFEE BREAK

11:05 – 11:40 AMTimothy Yu, Boston Children’s Hospital; Harvard Medical School

11:40 – 12:15 PMKevin Bender, University of California San Francisco

12:20 – 1:20 PM – LUNCH

1:20 – 1:30 PM – Remarks by Ana Mendez and Rajeev Jayavant, MIT RareNet Founders

1:30 – 1:40 PM – Remarks by Sally Kornbluth, President of MIT

1:40 – 2:15 PMChristopher Walsh, Boston Children’s Hospital; Harvard Medical School

2:15 – 2:50 PMSonia Vallabh, Broad Institute; MGH; Harvard Medical School

2:50 – 3:25 PMJoseph Buxbaum, Icahn School of Medicine at Mount Sinai

3:25 – 3:45 PM – COFFEE BREAK

3:45 – 4:05 PMMonica Coenraads, Rett Syndrome Research Trust

4:05 – 4:25 PMSamit Dasgupta, Duke University; FoxP1 Medical Research Foundation

4:25 – 4:30 PMCLOSING REMARKS
Robert Desimone, MIT McGovern Institute

4:30 – 6:00 PM – POSTER SESSION & NETWORKING RECEPTION